1-(5-(4-氨基-7-甲基-7H-吡咯并[2,3-d]嘧啶-5-基)二氢吲哚-1-基)-2-(3-(三氟甲基)苯基)乙酮
1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone;GSK2606414 (Synonyms: GSK 2606414)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
20 mg 50 mg 100 mg
Product Availability
In-stock
Price
$500.00
Member price
Product Availability
In-stock
Price
$550.00
Member price
Product Availability
In-stock
Price
$800.00
Member price
Quantity
- +
Product Overview
Product Name 1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone;GSK2606414 (Synonyms: GSK 2606414)
CAS1337531-36-8
FormulaC24H20F3N5O
MW451.44
AppearanceWhite powder
Storage condition Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

GSK2606414 is an orally available, selective protein kinase R-like ER kinase (PERK) inhibitor with an IC50 value of 0.4 nM. It can inhibit thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells and attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Because PERK mediates the unfolded protein response pathway, which has roles in neurotoxicity and cancer, inhibition of PERK signaling has potential applications for the treatment of cancer and also cognitive degeneration.


Related literature
Related
Sorry, no related items
History
1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone;GSK2606414 (Synonyms: GSK 2606414)